助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   巨大肾癌 在 泌尿科学 分类中 的翻译结果: 查询用时:0.065秒
图标索引 在分类学科中查询
所有学科
泌尿科学
肿瘤学
更多类别查询

图标索引 历史查询
 

巨大肾癌    
相关语句
  giant renal carcinoma
    CT Diagnosis of Giant Renal Carcinoma,Sarcomatoid Carcinoma and Carcinosarcoma
    巨大肾癌类肿瘤的CT诊断
短句来源
  giant renal carcinoma
    CT Diagnosis of Giant Renal Carcinoma,Sarcomatoid Carcinoma and Carcinosarcoma
    巨大肾癌类肿瘤的CT诊断
短句来源
  giant carcinoid of kidney
    Differential diagnosis between giant hamartoma of kidney and giant carcinoid of kidney with CT
    巨大肾错构瘤与巨大肾癌类肿瘤CT鉴别诊断
短句来源
    There is not clear limit between giant carcinoid of kidney and residual normal tissue of kidney.
    而巨大肾癌类肿瘤均有不同程度的坏死、液化、囊变及钙化与残存正常肾组织分界不清。
短句来源
查询“巨大肾癌”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Mitomycin C (MMC) was blended with polylactic acid (PLA) in the form of microsphefes which was considered to release drugs under control. Experimental studies confirmed their effects of tumor inhibition and sustaining release of drug. The PLA, MMC microspheres were injected through catheter into the renal arteries in 6 cases of renal cancer, 3 of which with bulky tumors were resected successfully with minimal bleeding and easiness in manipulation during the operation. The remaining 3 cases received a simple...

Mitomycin C (MMC) was blended with polylactic acid (PLA) in the form of microsphefes which was considered to release drugs under control. Experimental studies confirmed their effects of tumor inhibition and sustaining release of drug. The PLA, MMC microspheres were injected through catheter into the renal arteries in 6 cases of renal cancer, 3 of which with bulky tumors were resected successfully with minimal bleeding and easiness in manipulation during the operation. The remaining 3 cases received a simple chemicoembolization therapy with satisfactory effect. There was no serious complication encountered.

用聚乳酸(polylactic Acid)与丝裂霉素C(Mitomycin C)研制成可控释性微球-PLA·MMC,实验研究证明其抑瘤和缓释作用。1989年8月应用于临床,经动脉插管注入PLA·MMC治疗肾癌6例,其中3例巨大肾癌术中出血少,易剥离顺利切除,余3例晚期肾癌行单纯性化疗栓塞术,近期疗效满意。

Objective To explore the CT features of the giant hamartoma (angiomyolipoma)of kidney and giant carcinoid of kidney and their differential diagnosis. Methods Four patients with savgically and pathologically proved giant hamartoma of kidney and thirteen patients with sargically and pathologically proved giant carcinoid which comprised 2 carcinosarcoma,5 sarcomatoid carcinoma and 6 carcinoma underwent CT scans without and with contrast enhancement.CT data of all patients were analyzed retrospectively.Results On...

Objective To explore the CT features of the giant hamartoma (angiomyolipoma)of kidney and giant carcinoid of kidney and their differential diagnosis. Methods Four patients with savgically and pathologically proved giant hamartoma of kidney and thirteen patients with sargically and pathologically proved giant carcinoid which comprised 2 carcinosarcoma,5 sarcomatoid carcinoma and 6 carcinoma underwent CT scans without and with contrast enhancement.CT data of all patients were analyzed retrospectively.Results On CT images,giant hamartoma of kidney presented mostly fatty density and intratumoral major blood vessels,while carcinoid of kidney presented predominantly as destruction of renal parenchyma.Conclusion There is a clear limit between giant hamartoma of kidney and normal tissue of kidney.CT can clearly reveal fatty density which is a specific finding for the hamartoma,while giant carcimoid of kidney present necrosis,liguefaction,cysti from change,and calcification to different extent.There is not clear limit between giant carcinoid of kidney and residual normal tissue of kidney.

目的探讨巨大肾错构瘤的CT特征与肾癌类肿瘤的鉴别诊断。方法回顾性分析经手术病理证实的4例巨大肾错构瘤和13例巨大肾癌类肿瘤(包括2例癌肉瘤,5例肉瘤样癌,以及6例癌)的CT资料。所有病人均经CT平扫与增强扫描。结果巨大肾错构瘤主要CT表现为有脂肪CT值,肿瘤内可见粗大的血管。肾癌类肿瘤主要CT表现为肿瘤以破坏肾实质为主。结论巨大肾错构瘤与正常肾组织分界清楚,CT可见明确的脂肪密度,为错构瘤的CT特征性表现。而巨大肾癌类肿瘤均有不同程度的坏死、液化、囊变及钙化与残存正常肾组织分界不清。

Objective To explore the efficacy of arterial infusion chemotherapy combined with embolization for the treatment of giant carcinoma of the kidney.Methods Arterial infusion chemotherapy combined with embolization was performed through the renal artery in 32 cases of giant carcinoma of the kidney from April 1990 to April 2003.The chemotherapeutic agents were epirubicin(30~40 mg),mitomycin(20~30 mg),and 5-FU(500 mg).The embolization was conducted with anhydrous alcohol,sodium morrhuate,and lipiodol plus gelatin...

Objective To explore the efficacy of arterial infusion chemotherapy combined with embolization for the treatment of giant carcinoma of the kidney.Methods Arterial infusion chemotherapy combined with embolization was performed through the renal artery in 32 cases of giant carcinoma of the kidney from April 1990 to April 2003.The chemotherapeutic agents were epirubicin(30~40 mg),mitomycin(20~30 mg),and 5-FU(500 mg).The embolization was conducted with anhydrous alcohol,sodium morrhuate,and lipiodol plus gelatin sponge.Results The arterial infusion and embolization was successfully administered in all the 32 cases.Surgical resection was accomplished in 8 cases 1~3 months after the embolization,and little or no blood supply to the tumor was seen during the surgery.Pathological findings revealed marked necrosis of tumor cells with inflammatory cell infiltration around and fibrous proliferation as well as capillary embolization.The total response rate(CR+PR) was 87.5%(28/32) and the tumor decreased in size in 90.6% of the cases(29/32).The survival rates at 6 months,1-,2-,and 3-year were 78.1%(25/32),68.8%(22/32),46.9%(15/32),and 31.2%(10/32),respectively.The mean survival time was 41.5 months,with the longest time of 84 months.Conclusions Combination of infusion chemotherapy and embolization through the renal artery for the treatment of giant carcinoma of the kidney offers good clinical effects.

目的探讨巨大肾癌动脉灌注化疗联合栓塞免疫治疗的疗效。方法1990年4月~2003年4月,我院对32例巨大肾癌行动脉灌注栓塞术,灌注抗癌药物为表阿霉素30~40 mg、丝裂霉素20~30 mg、5-FU 500 mg;应用无水酒精、5%鱼肝油酸钠、40%碘油加明胶海绵颗粒施行肾动脉栓塞;干扰素和白介素-2辅助治疗。结果32例均成功施行动脉灌注栓塞术。8例栓塞术后1~3个月实施手术切除,术中见肿瘤血供基本中断,病理见肿瘤细胞坏死明显,周边有少许炎性淋巴细胞及不同程度纤维增生,毛细血管栓塞。总有效率为87.5%(28/32),6个月及1、2、3年生存率分别为78.1%(25/32)、68.8%(22/32)、46.9%(15/32)、31.2%(10/32),平均生存期41.5月。结论肾动脉灌注化疗联合栓塞与免疫治疗巨大肾癌,临床疗效较好。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关巨大肾癌的内容
在知识搜索中查有关巨大肾癌的内容
在数字搜索中查有关巨大肾癌的内容
在概念知识元中查有关巨大肾癌的内容
在学术趋势中查有关巨大肾癌的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社